Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2026-03-26 @ 3:17 PM
Ignite Modification Date: 2026-03-26 @ 3:17 PM
NCT ID: NCT07425535
Eligibility Criteria: Inclusion Criteria: * Adults who have no history of OAG * Have an ocular examination by a glaucoma specialist with no indications of OAG * Have normal optical coherence tomography findings in the retinal nerve fiber layer. * Over age 30 will be included from * Both sexes * All ethnic groups. * Optic neuropathy. * Both suspects and those with glaucoma damage will be included. * When both eyes meet inclusion and exclusion criteria, both eyes will be included in the study and statistical methods will be used to account for correlations between eyes within the same individual. Exclusion Criteria: * in whom sitting in an upright position is impossible due to physical disability * with ocular media opacity, corneal scarring, cataract or vitreous hemorrhage, that does not allow adequate imaging resolution. * in whom keeping the eyes open during the imaging procedure is not possible or uncomfortable. * who cannot perform home tonometry accurately at certification * who do not have reliable clinical Optical Coherence Tomography (OCT) testing. * with any form of glaucoma * with high myopia defined as refractive error \> -8 * with past keratorefractive surgery, corneal dystrophy, or corneal ectasia that would make self-tonometry measurements difficult to interpret * inability to understand English or with a language or hearing impairment
Healthy Volunteers: True
Sex: ALL
Minimum Age: 30 Years
Maximum Age: 90 Years
Study: NCT07425535
Study Brief:
Protocol Section: NCT07425535